Medical Properties Trust (MPW) Tops Q3 FFO by 1c, Offers FY11 Outlook
Get Alerts MPW Hot Sheet
Price: $4.56 --0%
EPS Growth %: -100.0%
Financial Fact:
Income (loss) from discontinued operations: 0
Today's EPS Names:
WF, CWBC, GLTO, More
EPS Growth %: -100.0%
Financial Fact:
Income (loss) from discontinued operations: 0
Today's EPS Names:
WF, CWBC, GLTO, More
Join SI Premium – FREE
Medical Properties Trust (NYSE: MPW) reported Q3 FFO of $0.18, $0.01 better than the analyst estimate of $0.17. Revenue for the quarter came in at $37.79 million versus the consensus estimate of $39.46 million.
Based solely on the portfolio as of September 30, 2011 and including the Hoboken acquisition and the completion of the Florence hospital currently under construction, the Company estimates that annualized Normalized FFO per share would approximate $0.76 to $0.80 per diluted share. The Company further estimates that its existing portfolio of assets plus approximately $275.0 million of assets expected to be acquired with available liquidity will generate Normalized FFO of between $0.93 and $0.97 per diluted share on an annualized basis once fully invested.
Based solely on the portfolio as of September 30, 2011 and including the Hoboken acquisition and the completion of the Florence hospital currently under construction, the Company estimates that annualized Normalized FFO per share would approximate $0.76 to $0.80 per diluted share. The Company further estimates that its existing portfolio of assets plus approximately $275.0 million of assets expected to be acquired with available liquidity will generate Normalized FFO of between $0.93 and $0.97 per diluted share on an annualized basis once fully invested.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intel slides in afterhours trading as Q1 revenue misses, Q2 outlook falls short
- L3Harris Technologies (LHX) Tops Q1 EPS by 15c; raises guidance
- Portland General Electric (POR) Tops Q1 EPS by 6c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!